Fatigue is an often ignored or undertreated complication of prostate cancer. Most, if not all, patients have received some form of therapy that will severely diminish testosterone, resulting in the presence of fatigue. With this complication comes loss of energy, muscle mass, and increased risk for bone injuries and/or other comorbidities. This lecture investigates available treatment options from a medical and holistic approach in the treatment of fatigue in prostate cancer survivors.
Contact hours available until 11/7/18.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures:
• Valre Welch, MSN, RN, CPNP - Consultant: Hollister Clinical Advisory Board
• Gina Powley, MSN, ANP-BC - Speakers Bureau: Astellas and Medivation
Speaker Disclosures:
Joanne Minnick, DNP, APRN, ACNP-BC, FNP-BC Advisory Board: Xtandi-Astellas and Consultant: Medicines Company – Orbativ, Astellas-Xtandi
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Learning Outcome:
At the conclusion of this activity, the learner will be able to list available options for a pharmacological and nonpharmacological management for patients with Prostate Cancer that suffer from fatigue.